STEX

MKT CAP:$41M

Streamex Corp.

Market Cap

$41M

Financial Services·Asset Management·🇺🇸 United States·NASDAQ

Financials·Asset Management·🇺🇸·NASDAQ

Stock Price

$0.90-$2.21 (-71.06%)

Apr 23, 2026

Company Details

BioSig Technologies, Inc. recently rebranded as Streamex Corp., effective September 12, 2025, following its merger with Streamex Exchange Corporation. The company shifted focus from healthcare technology to real-world asset tokenization, es...

CEO

Karl Henry McPhie

IPO Date

Sep 12, 2025

Website

www.streamex.com

Key Metrics TTM

Revenue

$0

-100.0% YoY

Net Income

-$463M

EPS (Diluted)

-$9.86

Free Cash Flow

-$10M

Revenue / Share

$0.00

Gross Margin

—

Operating Margin

—

Net Margin

—

FCF Margin

—

P/S

—

P/E

—

Earnings Reports

FY 2025

Mar 31, 2026

$0-100.0%EPS -$9.65

Q4 2025

Mar 31, 2026

$0-100.0%EPS -$8.51

Q3 2025

Nov 14, 2025

$0EPS -$0.47

Q2 2025

Jun 30, 2025

$0-100.0%EPS -$0.74

Q1 2025

Mar 31, 2025

$0-100.0%EPS -$0.14

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q4 23	$12.0K	-$81.0K	-$6M
Q1 24	$14.0K	-$64.0K	-$3M
Q2 24	$13.0K	$13.0K	-$5M
Q3 24	$0	$0	-$3M
Q4 24	$13.0K	$13.0K	-$1M
Q1 25	$0	$0	-$3M
Q2 25	$0	-$554.0K	-$20M
Q3 25	$0	-$1M	-$6M
Q4 25	$0	$2M	-$42M

Valuation

Quarter	P/S	P/E
Q4 23	—	—
Q1 24	—	—
Q2 24	—	—
Q3 24	4198.6x	—
Q4 24	4093.7x	—
Q1 25	6298.0x	—
Q2 25	12595.9x	—
Q3 25	11658.2x	—
Q4 25	—	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 23	-$3M	-$3M
Q1 24	-$1M	-$1M
Q2 24	-$1M	-$1M
Q4 24	-$474.0K	-$474.0K
Q1 25	-$1M	-$1M
Q2 25	-$1M	-$1M
Q3 25	-$5M	-$5M
Q4 25	-$3M	-$3M

Capital Expenditures

Quarter	CapEx
Q4 23	$4.0K
Q1 24	$0
Q2 24	$0
Q4 24	$0
Q1 25	$0
Q2 25	$0
Q3 25	$0
Q4 25	$0

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 24	+8.3%	-80.6%
Q1 25	-100.0%	-6.7%
Q2 25	-100.0%	+283.9%
Q3 25	—	+107.2%
Q4 25	-100.0%	+3380.9%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 23	$0	0.0%
Q1 24	$0	0.0%
Q2 24	$4M	34092.3%
Q4 24	-$53.0K	-407.7%
Q1 25	$2M	—
Q2 25	$0	—
Q3 25	$0	—
Q4 25	$55M	—

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q4 23	$1M	—	$5M
Q1 24	$238.0K	—	$3M
Q2 24	$342.0K	$5M	—
Q3 24	$156.0K	$3M	—
Q4 24	$96.0K	$1M	—
Q1 25	$6.0K	$3M	—
Q2 25	$19.0K	—	$20M
Q3 25	$6.0K	$5M	—
Q4 25	—	$40M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 23	$190.0K	$0	$190.0K
Q1 24	$416.0K	$0	$416.0K
Q2 24	$2M	$65.0K	$2M
Q3 24	$615.0K	$39.0K	$654.0K
Q4 24	$142.0K	$13.0K	$155.0K
Q1 25	$4M	$0	$4M
Q2 25	$3M	$0	$3M
Q3 25	$11M	$0	$11M
Q4 25	$20M	$10M	$30M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q4 23	9M	—	—
Q1 24	10M	+9.0%	—
Q2 24	13M	+31.0%	—
Q3 24	16M	+25.4%	—
Q4 24	17M	+7.5%	+92.6%
Q1 25	21M	+19.4%	+110.9%
Q2 25	28M	+33.3%	+114.5%
Q3 25	33M	+20.4%	+105.9%
Q4 25	48M	+43.8%	+175.4%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q4 23	$3.0K	4
Q1 24	$3.5K	4
Q2 24	$3.3K	4
Q3 24	$0	4
Q4 24	$500	26
Q1 25	$0	26
Q2 25	$0	26
Q3 25	$0	26
Q4 25	$0	6

Revenue / Employee